| Literature DB >> 27014568 |
John Whitaker1, William Rickaby2, Alistair Robson2, Farrah Bakr3, Jonathan White3, C Aldo Rinaldi1.
Abstract
Entities:
Keywords: Cardiac implantable electrical device; Extraction; Infection; Mycobacterium
Year: 2016 PMID: 27014568 PMCID: PMC4785634 DOI: 10.1016/j.hrcr.2015.10.012
Source DB: PubMed Journal: HeartRhythm Case Rep ISSN: 2214-0271
Figure 1A: Right-sided CIED cardiac implantable electrical device (CIED) site. B: Chronically discharging and poorly healing wound at site of recent extraction of a CIED. C and D: Photomicrographs of skin biopsy with suppurative granulomatous inflammation and foci of necrosis. (H & E staining; D ×40, E ×100). E: Following prolonged treatment with doxycycline and clarithromycin, the discharge stopped and the irritation at the CIED extraction site settled.
KEY TEACHING POINTS
CIED infection is increasing because of the increased number of devices being implanted, the increased number of revision procedures, and the changing clinical profile of patients treated with CIED. Successful treatment of CIED infection involves the combination of complete system removal and appropriate choice and duration of antibiotic therapy. The selection of appropriate antibiotic therapy depends critically on the identification of the causative organism. Acid-fast bacilli (AFB) infection should be considered as a possible cause in cases of persistent superficial inflammation or discharge at surgical wound sites (including those following CIED extraction) despite empiric antibiotic therapy. The high prevalence of |